SEATTLE, March 09, 2021, (MEDGADGET) — According to Coherent Market Insights, the global anosmia market is estimated to be valued at US$ 2,500.7 million in 2020 and is expected to exhibit a CAGR of 6.7% during the forecast period (2020-2027).
For more Information, Request PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-sample/4334
Key Trends and Analysis of the Global Anosmia Market:
Key trends in the market include rising incidence of anosmia and rising research activities by the market players & research organizations.
The increasing incidence of anosmia is expected to drive the market growth over the forecast period. For instance, according to an article published by the Fifth Sense in 2020, reports that amongst the common smell loss disorders idiopathic anosmia accounts 25% and congenital anosmia holds share of 1% in the U.K.
Rising research activities by the market players to develop novel treatment for anosmia is expected to drive the global anosmia market growth over the forecast period. For instance, in June 2019, Washington University School of Medicine, initiated the Phase II study, in order to evaluate the efficacy and safety of Budesonide in patients with coronavirus smell therapy for anosmia recovery. The study is expected to complete in December 2023.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/4334
Key Market Takeaways:
- The global anosmia market is expected to exhibit a CAGR of 6.7% during the forecast period (2020-2027), owing to rising product launches by the market players. For instance, in June 2020, Cadila Pharmaceuticals Limited launched Bilastine syrup (30 ml) and Bilastine tablets (20 mg), an antihistamine drug. This drug is used in the treatment of allergic rhinitis, which later develops anosmia.
- Among regions, North America is expected to hold a dominant position in the global anosmia market over the forecast period, owing to increasing cases of anosmia in the region. For instance, according to an article published by the National Center for Biotechnology Information (NCBI) in 2017, reports that a substantial portion i.e. around 4.3 million people, 65 years or older suffer from anosmia in the U.S.
- Key players operating in the global anosmia market include Mylan N.V., Pfizer Inc., Atom Pharma, RANBAXY LABORATORIES LIMITED, Alde Medi Impex, GlaxoSmithkline plc, Sandoz (Novasrtis AG), Inke S.A., Taj Pharmaceuticals Limited, and Sanofi, amongst others.
To know the latest trends and insights prevalent in this market press release, click the link below: https://www.coherentmarketinsights.com/press-release/anosmia-market-3594
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Treatment
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Key Highlights
- Product Pipeline
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- Merger and Acquisition Scenario
- Market Share Analysis
- Market Dynamics
- Anosmia Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- COVID-19 Impact on the Anosmia
- Global Anosmia Market, By Type, 2016 – 2027 (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Idiopathic Anosmia
- Congenital Anosmia
- Introduction
- Global Anosmia Market, By Treatment, 2016 – 2027 (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Nasal Endoscopy
- Imaging
- Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Decongestants
- Antihistamines
- Steroid Nasal Sprays
- Introduction
- Global Anosmia Market, By Region, 2016 – 2027 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 – 2027
- Regional Trends
- North America
- Market Size and Forecast, By Type, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Type, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Type, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Type, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Type, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Type, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2027 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Mylan N.V.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Pfizer Inc.
- Atom Pharma
- RANBAXY LABORATORIES LIMITED
- Alde Medi Impex
- GlaxoSmithkline pl
- Sandoz (Novasrtis AG)
- Inke S.A.
- Taj Pharmaceuticals Limited
- Strategies
- Sanofi
- Mylan N.V.
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837